Merck Sharp & Dohme, Wilson Facility recalls Vytorin (ezetimibe and simvastatin) tablets, 10 mg/20 mg, each tablet contains 10 mg ezetimibe and 20 mg simvastatin, Rx
Recalled October 14, 2015 · FDA recall D-0007-2016 · Merck Sharp & Dohme, Wilson Facility
Hazard
Presence of Foreign Tablet/Capsule: Vytorin 10 mg/40 mg tablets were found in bottles of Vytorin 10 mg/20 mg tablets. · FDA Class II
Units
N/A
Sold at
KY, MS and OH.
Description
Presence of Foreign Tablet/Capsule: Vytorin 10 mg/40 mg tablets were found in bottles of Vytorin 10 mg/20 mg tablets.
Product
Vytorin (ezetimibe and simvastatin) tablets, 10 mg/20 mg, each tablet contains 10 mg ezetimibe and 20 mg simvastatin, Rx Only, 1000 count Bottle, Manuf. For Merck Sharp & Dohme Corp, a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ 08889, NDC 66582-0312-82.
Manufacturer(s)
Merck Sharp & Dohme, Wilson Facility
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →